drugset / Trial / NCT05060731

Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding

NCT05060731

Phase 4 Not yet recruiting 570 enrolled University of Pecs
RandomizedParallel-groupSingle-blindTreatment

Summary

Anemia is a frequent complication of gastrointestinal bleeding, affecting 61% of the patients. Currently, anemia caused by gastrointestinal bleeding can be treated with iron supplementation. However, the dose and route of the administration are still a question. The FIERCE clinical trial aims to compare the effect of intravenous iron supplementation and oral iron replacement on mortality, unplanned emergency visits, and hospital readmissions in multimorbid patients with acute nonvariceal gastrointestinal bleeding.

Timeline

Start
2025-09-01
Primary completion
2027-12-31
Completion
2028-02-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferric carboxymaltose Other / unclassified 1000 mg Intravenous
Comparator Ferrous Sulfate Diagnostic / imaging agent 200 mg Oral
Comparator Ferrous Sulfate Diagnostic / imaging agent 300 mg Oral

Indications